Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'N-METHYLSPIPERONE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 45 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kestler, LP; Walker, E; Vega, EM
      Dopamine receptors in the brains of schizophrenia patients: a meta-analysis of the findings

      BEHAVIOURAL PHARMACOLOGY
    2. Rice, OV; Gatley, SJ; Shen, J; Huemmer, CL; Rogoz, R; DeJesus, OT; Volkow, ND; Gifford, AN
      Effects of endogenous neurotransmitters on the in vivo binding of dopamineand 5-HT radiotracers in mice

      NEUROPSYCHOPHARMACOLOGY
    3. Gjedde, A; Wong, DF
      Quantification of neuroreceptors in living human brain. V. Endogenous neurotransmitter inhibition of haloperidol binding in psychosis

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    4. Syvalahti, EKG; Rakkolainen, V; Aaltonen, J; Lehtinen, V; Hietala, J
      Striatal D-2 dopamine receptor density and psychotic symptoms in schizophrenia: a longitudinal study

      SCHIZOPHRENIA RESEARCH
    5. Ishizu, K; Smith, DF; Bender, D; Danielsen, E; Hansen, SB; Wong, DF; Cumming, P; Gjedde, A
      Positron emission tomography of radioligand binding in porcine striatum invivo: Haloperidol inhibition linked to endogenous ligand release

      SYNAPSE
    6. Tsukada, H; Harada, N; Nishiyama, S; Ohba, H; Kakiuchi, T
      Cholinergic neuronal modulation alters dopamine D-2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: Positron emission tomography studies with microdialysis in the conscious monkey brain

      JOURNAL OF NEUROSCIENCE
    7. Kaasinen, V; Ruottinen, HM; Nagren, K; Lehikoinen, P; Oikonen, T; Rinne, JO
      Upregulation of putaminal dopamine D-2 receptors in early Parkinson's disease: A comparative PET study with [C-11]raclopride and [C-11]N-methylspiperone

      JOURNAL OF NUCLEAR MEDICINE
    8. Okubo, Y; Suhara, T; Suzuki, K; Kobayashi, K; Inoue, O; Terasaki, O; Someya, Y; Sassa, T; Sudo, Y; Matsushima, E; Iyo, M; Tateno, Y; Toru, M
      Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography

      LIFE SCIENCES
    9. Moresco, RM; Loc'h, C; Ottaviani, M; Guibert, B; Leviel, V; Maziere, M; Fazio, F; Maziere, B
      Effects of dopamine on the in vivo binding of dopamine D-2 receptor radioligands in rat striatum

      NUCLEAR MEDICINE AND BIOLOGY
    10. Ishiwata, K; Hayakawa, N; Ogi, N; Oda, K; Toyama, H; Endo, K; Tanaka, A; Senda, M
      Comparison of three PET dopamine D-2-like receptor ligands, [C-11]raclopride, [C-11]nemonapride and [C-11]N-methylspiperone, in rats

      ANNALS OF NUCLEAR MEDICINE
    11. Nader, MA; Grant, KA; Gage, HD; Ehrenkaufer, RL; Kaplan, JR; Mach, RH
      PET imaging of dopamine D-2 receptors with [F-18]fluoroclebopride in monkeys: Effects of isoflurane- and ketamine-induced anesthesia

      NEUROPSYCHOPHARMACOLOGY
    12. Sadzot, B; Sheldon, J; Flesher, J; Dannals, RF; Schachat, AP; Frost, JJ
      Tracers for imaging melanin with positron emission tomography

      SYNAPSE
    13. Inoue, O; Wakahara, S; Kobayashi, K; Gee, A
      Enhancement of H-3-N-methylspiperone binding but not H-3-raclopride binding in mouse striatum by MK-801: evidence that factors other than competitionby endogenous dopamine are responsible for changes in D-2 receptor bindingin vivo

      JOURNAL OF NEURAL TRANSMISSION
    14. Inoue, O; Kobayashi, K; Hosoi, R; Yamaguchi, M; Gee, A
      Discrepancies in apparent dopamine D2 receptor occupancy between H-3-raclopride and H-3-N-methylspiperone

      JOURNAL OF NEURAL TRANSMISSION
    15. Hietala, J; Nagren, K; Lehikoinen, P; Ruotsalainen, U; Syvalahti, E
      Measurement of striatal D-2 dopamine receptor density and affinity with [C-11]-raclopride in vivo: A test-retest analysis

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    16. Ekesbo, A; Torstenson, R; Hartvig, P; Carlsson, A; Sonesson, C; Waters, N; Tedroff, J; Langstrom, B
      Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [C-11]SCH23390 and [C-11]raclopride binding in primate brains

      NEUROPHARMACOLOGY
    17. Bigliani, V; Pilowsky, LS
      In vivo neuropharmacology of schizophrenia

      BRITISH JOURNAL OF PSYCHIATRY
    18. Tsukada, H; Nishiyama, S; Kakiuchi, T; Ohba, H; Sato, K; Harada, N
      Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [C-11]raclopride?: PET studies combined with microdialysis in conscious monkeys

      BRAIN RESEARCH
    19. Borbely, K; Brooks, RA; Wong, DF; Burns, RS; Cumming, P; Gjedde, A; Di Chiro, G
      NMSP binding to dopamine and serotonin receptors in MPTP-induced parkinsonism: relation to dopa therapy

      ACTA NEUROLOGICA SCANDINAVICA
    20. Laruelle, M
      Imaging dopamine transmission in schizophrenia

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    21. HAGBERG G; GEFVERT O; BERGSTROM M; WIESELGREN IM; LINDSTROM L; WIESEL FA; LANGSTROM B
      N-[C-11]METHYLSPIPERONE PET, IN CONTRAST TO [C-11] RACLOPRIDE, FAILS TO DETECT D-2 RECEPTOR OCCUPANCY BY AN ATYPICAL NEUROLEPTIC

      PSYCHIATRY RESEARCH-NEUROIMAGING
    22. MAGGOS CE; TSUKADA H; KAKIUCHI T; NISHIYAMA S; MYERS JE; KREUTER J; SCHLUSSMAN SD; UNTERWALD EM; HO A; KREEK MJ
      SUSTAINED WITHDRAWAL ALLOWS NORMALIZATION OF IN-VIVO [C-11] N-METHYLSPIPERONE DOPAMINE D-2 RECEPTOR-BINDING AFTER CHRONIC BINGE COCAINE - APOSITRON-EMISSION-TOMOGRAPHY STUDY IN RATS

      Neuropsychopharmacology
    23. NAKANO T; KOBAYASHI K; HOSOI R; WAKAHARA S; WATANABE Y; NISHIMURA T; INOUE O
      EFFECTS OF THE GABAERGIC SYSTEM ON IN-VIVO BINDING OF [H-3]N-METHYLSPIPERONE

      Neuropharmacology
    24. YOSHII F; KOZUMA R; TAKAHASHI W; HAIDA M; TAKAGI S; SHINOHARA Y
      MAGNETIC-RESONANCE-IMAGING AND C-11 N-METHYLSPIPERONE POSITRON EMISSION TOMOGRAPHY STUDIES IN A PATIENT WITH THE INTERVAL FORM OF CARBON-MONOXIDE POISONING/

      Journal of the neurological sciences
    25. Zawarynski, P; Tallerico, T; Seeman, P; Lee, SP; O'Dowd, BF; George, SR
      Dopamine D2 receptor dimers in human and rat brain

      FEBS LETTERS
    26. WILSON JM; SANYAL S; VANTOL HHM
      DOPAMINE D-2 AND D-4 RECEPTOR LIGANDS - RELATION TO ANTIPSYCHOTIC ACTION

      European journal of pharmacology
    27. SHIHABUDDIN L; BUCHSBAUM MS; HAZLETT EA; HAZNEDAR MM; HARVEY PD; NEWMAN A; SCHNUR DB; SPIEGELCOHEN J; WEI TS; MACHAC J; KNESAUREK K; VALLABHAJOSULA S; BIREN MA; CIARAVOLO TM; LUUHSIA C
      DORSAL STRIATAL SIZE, SHAPE, AND METABOLIC-RATE IN NEVER-MEDICATED AND PREVIOUSLY MEDICATED SCHIZOPHRENICS PERFORMING A VERBAL-LEARNING TASK

      Archives of general psychiatry
    28. FARDE L
      BRAIN IMAGING OF SCHIZOPHRENIA - THE DOPAMINE HYPOTHESIS

      Schizophrenia research
    29. SEEMAN P; CORBETT R; VANTOL HHM
      ATYPICAL NEUROLEPTICS HAVE LOW-AFFINITY FOR DOPAMINE D-2 RECEPTORS ORARE SELECTIVE FOR D-4 RECEPTORS - REPLY

      Neuropsychopharmacology
    30. SEEMAN P; GUAN HC; NOBREGA J; JIWA D; MARKSTEIN R; BALK JH; PICETTI R; BORRELLI E; VANTOL HHM
      DOPAMINE D2-LIKE SITES IN SCHIZOPHRENIA, BUT NOT IN ALZHEIMERS, HUNTINGTONS, OR CONTROL BRAINS, FOR [H-3] BENZQUINOLINE

      Synapse
    31. HARTVIG P; TORSTENSON R; TEDROFF J; WATANABE Y; FASTH KJ; BJURLING P; LANGSTROM B
      AMPHETAMINE EFFECTS ON DOPAMINE RELEASE AND SYNTHESIS RATE STUDIED INTHE RHESUS-MONKEY BRAIN BY POSITRON EMISSION TOMOGRAPHY

      Journal of neural transmission
    32. WONG DF; PEARLSON GD; TUNE LE; YOUNG LT; MELTZER CC; DANNALS RF; RAVERT HT; REITH J; KUHAR MJ; GJEDDE A
      QUANTIFICATION OF NEURORECEPTORS IN THE LIVING HUMAN BRAIN .4. EFFECTOF AGING AND ELEVATIONS OF D-2-LIKE RECEPTORS IN SCHIZOPHRENIA AND BIPOLAR ILLNESS

      Journal of cerebral blood flow and metabolism
    33. TAMMINGA CA; CONLEY RR
      THE APPLICATION OF NEUROIMAGING TECHNIQUES TO DRUG DEVELOPMENT

      The Journal of clinical psychiatry
    34. UNTERWALD EM; TSUKADA H; KAKIUCHI T; KOSUGI T; NISHIYAMA S; KREEK MJ
      USE OF POSITRON-EMISSION-TOMOGRAPHY TO MEASURE THE EFFECTS OF NALMEFENE ON D-1 AND D-2 DOPAMINE-RECEPTORS IN RAT-BRAIN

      Brain research
    35. GJEDDE A; REITH J; WONG DF
      IN SCHIZOPHRENIA, SOME DOPAMINE D-2-LIKE RECEPTORS ARE STILL ELEVATED

      PSYCHIATRY RESEARCH-NEUROIMAGING
    36. GIFFORD AN; GATLEY SJ; ASHBY CR
      ENDOGENOUSLY RELEASED DOPAMINE INHIBITS THE BINDING OF DOPAMINERGIC PET AND SPECT LIGANDS IN SUPERFUSED RAT STRIATAL SLICES

      Synapse
    37. HIETALA J; SYVALAHTI E
      DOPAMINE IN SCHIZOPHRENIA

      Annals of medicine
    38. SCHLOESSER R; SIMKOWITZ P; BARTLETT EJ; WOLKIN A; SMITH GS; DEWEY SL; BRODIE JD
      THE STUDY OF NEUROTRANSMITTER INTERACTIONS USING POSITRON EMISSION TOMOGRAPHY AND FUNCTIONAL COUPLING

      Clinical neuropharmacology
    39. TSUKADA H; KREUTER J; MAGGOS CE; UNTERWALD EM; KAKIUCHI T; NISHIYAMA S; FUTATSUBASHI M; KREEK MJ
      EFFECTS OF BINGE PATTERN COCAINE ADMINISTRATION ON DOPAMINE D-1 AND D-2 RECEPTORS IN THE RAT-BRAIN - AN IN-VIVO STUDY USING POSITRON EMISSION TOMOGRAPHY

      The Journal of neuroscience
    40. GOYER PF; BERRIDGE MS; MORRIS ED; SEMPLE WE; COMPTONTOTH BA; SCHULZ C; WONG DF; MIRALDI F; MELTZER HY
      PET MEASUREMENTS OF NEURORECEPTOR OCCUPANCY BY TYPICAL AND ATYPICAL NEUROLEPTICS

      The Journal of nuclear medicine
    41. KUWABARA K; HITOSHI S; NUKINA N; ISHII K; MOMOSE T; KUBOTA S; SEYAMA Y; KANAZAWA I
      PET ANALYSIS OF A CASE OF CEREBROTENDINOUS XANTHOMATOSIS PRESENTING HEMIPARKINSONISM

      Journal of the neurological sciences
    42. NG GYK; ODOWD BF; LEE SP; CHUNG HT; BRANN MR; SEEMAN P; GEORGE SR
      DOPAMINE D2 RECEPTOR DIMERS AND RECEPTOR-BLOCKING PEPTIDES

      Biochemical and biophysical research communications
    43. HALL H; HALLDIN C; NYBERG S; FARDE L; SEDVALL G
      EFFECT OF CLOZAPINE AND RISPERIDONE ON 5-HT2 AND D-2-DOPAMINE RECEPTOR-BINDING IN THE POSTMORTEM HUMAN BRAIN - AN AUTORADIOGRAPHIC STUDY

      European neuropsychopharmacology
    44. SUHARA T; INOUE O; KOBAYASHI K; SATOH T; TATENO Y
      AN ACUTE EFFECT OF TRIAZOLAM ON MUSCARINIC CHOLINERGIC RECEPTOR-BINDING IN THE HUMAN BRAIN MEASURED BY POSITRON EMISSION TOMOGRAPHY

      Psychopharmacology
    45. IYO M; NISHIO M; ITOH T; FUKUDA H; SUZUKI K; YAMASAKI T; FUKUI S; TATENO Y
      DOPAMINE D-2 AND SEROTONIN S-2 RECEPTORS IN SUSCEPTIBILITY TO METHAMPHETAMINE PSYCHOSIS DETECTED BY POSITRON EMISSION TOMOGRAPHY

      PSYCHIATRY RESEARCH-NEUROIMAGING


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/12/19 alle ore 15:08:50